media centre
Join us @ Keystone! March 24-28 Innate and Non-Classical Immune Cells in Cancer Immunotherapy
20 February
media centre
All media
All media
Twitter
Feed
news
news
publications
publications
schedule
schedule
Quantifying NK cell growth and survival ...
Great work team! https://t.co/K5YM8Ps44o
Throwback Tuesday to the academic work r...
Harnessing the 'Natural Killer' within u...
A simply amazing response to the recent ...
Only 10 days till the first @KeystoneSym...
Congratulations to our CSO for winning the 2019 Jacques Miller Medal
Well deserved recognition. Congrats to o...
Join us @ Keystone! March 24-28 Innate and Non-Classical Immune Cells in Cancer Immunotherapy
Amazing response to the @KeystoneSymp th...
@LorneCancer conference starts today. Se...
He eats, sleeps, breathes and drives NKC...
31st Annual Lorne Cancer Conference
The Emergence of Natural Killer Cells as a Major Target in Cancer Immunotherapy
We are LIVE! https://t.co/fu8vunDAEv Ch...
Did you know that NK cells can recognize...
RT @JoeCursons: Off to a flying start fo...
RT @JohnCendpts: Bristol-Myers inks a $7...
A tremendous study by the Gebhardt group...
Abstract deadline for #innate #immunothe...
Congrats @Dr_Nick_Bikes https://t.co/h5m...
A well deserved congratulations to our f...
New work from our founders. Ablating NK ...
RT @MadsDegnbol: This article describes ...
just mind boggling how this could happen...
Really looking forward to Lorne Cancer C...
This approach will accelerate NK cell #i...
when a peer review journal is committed ...
https://t.co/rDNsOFyJkv
Some great opportunities here. @Malmberg...
Pretty cool tech. Off-the-shelf is the w...
Great line-up ;-) Well done @DGCarnegie ...
https://t.co/M8iBYlcu0r https://t.co/cL4...
New speakers added to the program for th...
Welcome to our new website!